SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia

BACKGROUND: Aberrant DNA methylation plays a crucial role in the progression of myeloid neoplasms. Previously, our literature reported that slit guidance ligand 2 (SLIT2) promoter methylation was associated with disease progression and indicated a poor prognosis in patients with myelodysplastic synd...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, De-long, Wang, Yun, Zhang, Ting-juan, Chu, Ming-qiang, Xu, Zi-jun, Yuan, Qian, Ma, Ji-chun, Lin, Jiang, Qian, Jun, Zhou, Jing-dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677675/
https://www.ncbi.nlm.nih.gov/pubmed/36411451
http://dx.doi.org/10.1186/s40001-022-00899-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677675/
https://www.ncbi.nlm.nih.gov/pubmed/36411451
http://dx.doi.org/10.1186/s40001-022-00899-2

Ejemplares similares